Transdermal Tech Breakthrough,High-Efficiency Penetration Reinvents Bio-Active Value

Popular Searches: Transdermal Cyclic Peptide Cosmetic Raw MaterialsManufacturer Raw Material OEM / Customization Transdermal Peptide Tech

Mellgen BiotechInnovative 3rd-Gen Transdermal Peptide Fusion Tech

Utilizing AI molecular design, synthetic biology foundations, genetic engineering, and fermentation technology to develop next-generation transdermal-enhanced bio-active molecules, realizing the green development and industrialization of featured functional bio-resources such as protein peptides, plant polysaccharides, and microbial fermentation products, greatly enhancing the utilization efficiency of active molecules in skin repair and health care.

22 Years R&D Experience

22 Years R&D Experience

Through 22 years of dedicated scientific research, we have accumulated profound R&D and application experience in biological transdermal technology, focusing on becoming a highly trusted innovative enterprise in this field.

SCI Journal Publications

SCI Journal Publications

Published over 30 high-quality papers in top international academic journals including Nature and Science, with cumulative impact factors exceeding 200, attracting widespread global academic acclaim.

6 R&D Laboratories

6 R&D Laboratories

A comprehensive R&D laboratory system comprising 6 major labs: AI Molecular Design, Molecular Cloning Biology, Cell Biology, Synthetic Biology, Bio-Transdermal Delivery, and Skin Efficacy Testing.

Sci-Tech Fund Support

Sci-Tech Fund Support

Multiple R&D projects supported by the National Youth Science Fund, National Postdoctoral Research Fund, USTC Youth Science Fund, and Shenzhen Science & Tech Innovation Fund.

NMPA Filing & Registration

NMPA Filing & Registration

High-quality bio-materials have completed standard safety information and DMF filing with the NMPA. Backed by an advanced AI-driven end-to-end R&D system, we rapidly respond to client demands and deliver mass production.

4 Rare Resource Libraries

4 Rare Resource Libraries

Equipped with 4 globally scarce proprietary bio-resource repositories: Transdermal Peptide Library, Skin Active Peptide & Protein Library, Microbial Genetic Element Library, and Microbial Strain Library.

22 Years R&D Experience

SCI Journal Publications

6 R&D Laboratories

Sci-Tech Fund Support

NMPA Filing & Registration

4 Rare Resource Libraries

Biological Transdermal Delivery Platform

Biological Transdermal Drug Delivery Technologyis inUniversity of Science and Technology of China (USTC) platform Team oneTransdermal PeptidesmoleculesTechnology,using PeptidesAs a moleculesresolvebiosubstance major moleculesTransdermal Absorption 。Research published in the world-renowned journal 《Nature Biotechnology》,and honored with “Top 10 News in China Basic Research”,international transdermal authority Mark Prausnit highly recognized。
Biological Transdermal Delivery Platform
Mellgen BiotechInvented via synthetic biology “Transdermal PeptidesFusion Technology”,can enhanceTransdermal Peptides Bioactivitymajor moleculesmajor major become; times enhance Transdermal Peptidesprocess canand ,research published in Tier-1 pharmacy journal 《Molecular Pharmaceutics》 journal。CompanyEquipped with Transdermal PeptidesSequencelibrary using and library。
Penetration Pathways of Transdermal Peptides
Penetration Pathways of Transdermal Peptides
3rd-Generation Transdermal Technology
3rd-Generation Transdermal Technology

R&D and Manufacturing CenterProduction strength

  • R&D and Manufacturing Center

    Mellgen Biotech · R&D Strengths

    Equipped with Biological Transdermal Technologyincubation platformunits ,capable of conducting moleculesbiosubstance science、cell biologysubstance science、Fermentationand purification engineering、formulation development and human Efficacy Verificationand othersR&D operations。1000 platform GMP Cell Factory,equipped with 7 units Fermenter,totaling 5 tons;2000 m² formulation platform,including freeze-dried powder lines,emulsification production lines。The company commands an end-to-end chain from Upstream Molecular Design、Process Development and efficacy validation to downstream raw material and finished product manufacturingonindustrial chain。

TechnologyBreakthrough,production aqua platformAcademic Achievements

full global Biological Transdermal Technology original team,brings together 10leading R&D scientists,with members from USAStanford University、University of Science and Technology of China (USTC)、The University of Hong Kong (HKU)using and South China University of Technology (SCUT),including professors、PhDs and postdocs。We strictly protect molecular structures,molecular sequences, manufacturing processes, scientific formulations,strains, and proprietary technologies with comprehensive protection,building solid competitive barriers!
left
right

Application Fields

Mellgen BiotechInvented via synthetic biology 3generation “Transdermal PeptidesFusion Technology”;significantly enhancing bio-active Ingredientstransdermal absorption efficiency,effectively optimizing formulation development costs(*Laboratoryresearch comparison data);
Biological Transdermal TechnologyAs a platform units Technologycan be widely applied in biosubstance Technologyusing and major Healthy Beauty sectors。
  • Medical Aesthetics Sector

    Medical Aesthetics SectorEnhancing Transdermal Delivery of Botulinum Toxin Type A
    Enhancing Transdermal Delivery of Epidermal Growth Factor (EGF)
    Enhancing Transdermal Delivery of Hyaluronic Acid

  • Pharmaceutical SectorEnhancing Transdermal Delivery of RNA Therapeutics
    Promoting Bioactivitymoleculesvia Absorption

    Pharmaceutical Sector
  • Raw Material OEM / Customization

    Raw Material OEM / CustomizationisRaw Material Customization ,isbioproduction,
    canrealizing ,Clients